Published in Medical Letter on the CDC and FDA, July 6th, 2003
According to published research from Mexico, "The objective of this study was to characterize the kinetics' of the cellular and humoral immune responses elicited by measles vaccine given to previously immune adults."
"The cellular and humoral immune responses to measles were measured in seven healthy adults, before vaccination and at 1, 2, 3, and 4 weeks and 3 months after vaccination, using measles-specific T-cell proliferation and plaque reduction neutralization assays," reported Rosa Maria Wong-Chew and colleagues at the Universidad...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA